In HCC tissues harboring the F270I mutation, elevated p53 levels were observed, suggesting a structural disruption that weakens DNA binding, leading to p53 accumulation and potentially contributing to tumor progression. The gene discussed is TP53; the disease is hepatocellular carcinoma.